These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 16322599)

  • 1. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
    Duncan MD; Wilkes DS
    Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of allorecognition: implications for transplantation tolerance.
    Game DS; Lechler RI
    Transpl Immunol; 2002 Aug; 10(2-3):101-8. PubMed ID: 12216939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of immunosuppression by DNA transfer in transplantation.
    McDaniel DO
    J Long Term Eff Med Implants; 2002; 12(2):131-47. PubMed ID: 12463070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplant immunology for non-immunologist.
    Heeger PS; Dinavahi R
    Mt Sinai J Med; 2012; 79(3):376-87. PubMed ID: 22678861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect allorecognition in solid organ transplantation.
    Harris PE; Cortesini R; Suciu-Foca N
    Rev Immunogenet; 1999; 1(3):297-308. PubMed ID: 11256421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of T cells in graft rejection and transplantation tolerance.
    Issa F; Schiopu A; Wood KJ
    Expert Rev Clin Immunol; 2010 Jan; 6(1):155-69. PubMed ID: 20383898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era.
    Thorsby E; Pfeffer P; Leivestad T
    Transplant Proc; 2004 Mar; 36(2 Suppl):16S-21S. PubMed ID: 15041301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells: first steps of clinical application in solid organ transplantation.
    van der Net JB; Bushell A; Wood KJ; Harden PN
    Transpl Int; 2016 Jan; 29(1):3-11. PubMed ID: 25981203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.
    Trzonkowski P; Zilvetti M; Friend P; Wood KJ
    Transplantation; 2006 Nov; 82(10):1342-51. PubMed ID: 17130784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in immunosuppression for renal transplantation.
    Durrbach A; Francois H; Beaudreuil S; Jacquet A; Charpentier B
    Nat Rev Nephrol; 2010 Mar; 6(3):160-7. PubMed ID: 20125095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propagation and characterization of lymphocytes from transplant biopsies.
    Duquesnoy RJ; Trager JD; Zeevi A
    Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the Art: Role of the Dendritic Cell in Induction of Allograft Tolerance.
    Rosen SJ; Harris PE; Hardy MA
    Transplantation; 2018 Oct; 102(10):1603-1613. PubMed ID: 29677072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells,tolerance and therapy of organ allograft rejection.
    Raimondi G; Thomson AW
    Contrib Nephrol; 2005; 146():105-120. PubMed ID: 15567925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines and transplantation: a clinical perspective.
    Gaston RS
    Transplant Sci; 1994 Dec; 4 Suppl 1():S9-19. PubMed ID: 7627452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individuality: the barrier to optimal immunosuppression.
    Kahan BD
    Nat Rev Immunol; 2003 Oct; 3(10):831-8. PubMed ID: 14523389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
    Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
    J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.